1140 companies

Psyence Biomedical

Market Cap: US$1.9m

Engages in the development of botanical psilocybin-based psychedelic medicines.

PBM

US$3.07

7D

-42.1%

1Y

-95.3%

Nascent Pharma Holdings

Market Cap: US$1.9m

Engages in the protection and commercialization of cannabis patents.

NASC

US$0.021

7D

-17.2%

1Y

168.8%

Enveric Biosciences

Market Cap: US$1.9m

A biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.

ENVB

US$0.61

7D

-3.2%

1Y

-91.5%

Breakthrough Chemistry

Market Cap: US$1.8m

Develops compounds and formulations that defy the norms prevalent in chemical industries.

BKTH

US$0.19

7D

90.0%

1Y

-54.4%

Kaya Holdings

Market Cap: US$1.8m

A vertically integrated legal cannabis enterprise, operates psychedelic treatment clinics and medical cannabis dispensaries in the United States.

KAYS

US$0.052

7D

5.3%

1Y

10.5%

Resonate Blends

Market Cap: US$1.8m

Engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine.

KOAN

US$0.013

7D

63.4%

1Y

68.6%

Agentix

Market Cap: US$1.8m

A clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.

AGTX

US$0.045

7D

28.6%

1Y

-10.0%

OMID Holdings

Market Cap: US$1.8m

A health and wellness company, engages in the manufacture and sale of CBD-based products.

OMID

US$0.019

7D

1.3%

1Y

-23.4%

AXIM Biotechnologies

Market Cap: US$1.8m

Develops diagnostic healthcare solutions for ophthalmological conditions.

AXIM

US$0.0052

7D

13.8%

1Y

-14.8%

Evofem Biosciences

Market Cap: US$1.7m

A biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.

EVFM

US$0.014

7D

4.6%

1Y

48.9%

CBD Life Sciences

Market Cap: US$1.7m

Engages in the development and marketing a line of cannabidiol based organic products.

CBDL

US$0.0004

7D

33.3%

1Y

-33.3%

Endexx

Market Cap: US$1.6m

Develops and sells hemp-derived products for the health and wellness market under the CBD Unlimited brand in the United States and internationally.

EDXC

US$0.0025

7D

-15.3%

1Y

-79.3%

Vaccinex

Market Cap: US$1.6m

A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.

VCNX

US$0.55

7D

-21.4%

1Y

-83.2%

LiveCare

Market Cap: US$1.5m

Focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach.

LVCE

US$0.025

7D

0%

1Y

-91.6%

Longevity Health Holdings

Market Cap: US$1.5m

A bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products.

XAGE

US$0.90

7D

-9.8%

1Y

-92.0%

Body and Mind

Market Cap: US$1.5m

Body and Mind Inc. cultivates, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, Ohio, Illinois, and New Jersey in the United States.

BMMJ

US$0.01

7D

0%

1Y

-65.3%

Enzolytics

Market Cap: US$1.4m

Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

ENZC

US$0.0003

7D

0%

1Y

-83.3%

ZyVersa Therapeutics

Market Cap: US$1.4m

Operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases.

ZVSA

US$0.18

7D

10.1%

1Y

-92.3%

AJ1G

Market Cap: US$1.3m

Global Consortium Inc. operates as a diversified cannabis holding company in Florida.

AJYG

US$0.022

7D

0%

1Y

n/a

Galera Therapeutics

Market Cap: US$1.3m

A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.

GRTX

US$0.018

7D

-10.0%

1Y

-74.7%

Allied

Market Cap: US$1.3m

A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.

ALID

US$0.011

7D

0%

1Y

-78.7%

American Green

Market Cap: US$1.3m

Operates as a technology company in the medical cannabis industry in the United States.

ERBB

US$0.0003

7D

0%

1Y

0%

Ocean Biomedical

Market Cap: US$1.3m

A biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States.

OCEA

US$0.0056

7D

-9.7%

1Y

-99.4%

Halberd

Market Cap: US$1.2m

A biotech company, develops treatments for neurodegenerative diseases.

HALB

US$0.0019

7D

-12.6%

1Y

-62.6%

Biomind Labs

Market Cap: US$1.2m

A biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.

BMND.F

US$0.016

7D

0%

1Y

-96.8%

Nascent Biotech

Market Cap: US$1.2m

A clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer.

NBIO

US$0.007

7D

-17.6%

1Y

-85.0%

GelStat

Market Cap: US$1.1m

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.

GSAC

US$0.0003

7D

-25.0%

1Y

0%

Petros Pharmaceuticals

Market Cap: US$1.1m

A healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies.

PTPI

US$0.026

7D

-8.6%

1Y

-99.7%

VG Life Sciences

Market Cap: US$1.1m

A biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation.

VGLS

US$0.0001

7D

0%

1Y

0%

Core One Labs

Market Cap: US$1.1m

Operates as a psychedelic research and development company.

CLAB.F

US$0.022

7D

10.4%

1Y

-75.9%

Target Group

Market Cap: US$1.0m

Target Group Inc. cultivates, processes, and distributes curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States.

CBDY

US$0.0017

7D

0%

1Y

-19.0%

AXM Pharma

Market Cap: US$1.0m

Manufactures and sells over-the-counter and prescription pharmaceutical products in the People's Republic of China.

AXMP

US$0.0001

7D

0%

1Y

n/a

International Stem Cell

Market Cap: US$1.0m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

ISCO

US$0.13

7D

-8.5%

1Y

83.1%

Premier Biomedical

Market Cap: US$1.0m

A research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases.

BIEI

US$0.00074

7D

-6.3%

1Y

-26.0%

Unity Biotechnology

Market Cap: US$1.0m

A biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging.

UNBX

US$0.06

7D

0%

1Y

-95.8%

EV Biologics

Market Cap: US$984.7k

A biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics.

YECO

US$0.096

7D

11.1%

1Y

-67.4%

Page 24 of 32